LFWD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Lifeward Ltd (LFWD) is not a strong buy for a beginner investor with a long-term focus at this time. The technical indicators, options data, and financial performance do not suggest a compelling entry point. While there are some positive catalysts, such as the partnership with Oramed Pharmaceuticals, the company's financials and recent reverse stock split raise concerns about its stability. A 'hold' is recommended until more favorable signals or financial improvements emerge.
The technical indicators for LFWD are mixed to bearish. The MACD is below zero and negatively contracting, the RSI is neutral at 60.757, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock price is currently near a resistance level (R1: 6.752), which may limit upward momentum.
The partnership with Oramed Pharmaceuticals could provide up to $47 million in capital for growth initiatives. Gross margin has improved significantly, up 20.62% YoY.
EPS dropped significantly (-42.86% YoY), and net income remains negative.
In Q3 2025, revenue increased marginally by 1.09% YoY to $6,195,000. Net income improved slightly but remains negative at -$3,170,000. EPS dropped to -0.2, down 42.86% YoY, indicating worsening profitability. Gross margin increased to 43.7%, showing some operational improvement.
No data available for analyst ratings or price target changes.
